Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Salah-Eddin Al-Batran

Name: FAST: a Phase III trial of an anti-CLDN18.2 antibody GEJ adenocarcinoma
Uploaded: 2016-06-03T00:00:00.000Z
Duration: 8 min 41 s
Description: Press brief by Salah-Eddin Al-Batran, MD of the Krankenhaus Nordwest-University Cancer Center, Frankfurt, Germany, at the 2016 Annual Meeting of the American Society of Clinical Oncology (ASCO), held in Chicago, IL.

Krankenhaus Nordwest-University Cancer Center

Sorry, no posts matched your criteria.

Salah-Eddin Al-Batran

Cookie settings